Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPorvair Regulatory News (PRV)

Share Price Information for Porvair (PRV)

Share Price is delayed by 15 minutes
Get Live Data
794.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 4.00 (0.505%)
Market Cap: £366.00m
PRV Live PriceLast checked at - London Stock Exchange

Intraday Porvair Share Chart

Director/PDMR Shareholding

28 Jun 2019 11:30

RNS Number : 8425D
Porvair PLC
28 June 2019
 

 

Porvair plc ("Porvair" or the "Company")

Director's Shareholding

The Company was notified on 27 June 2019 of the following exercises of Long Term Share Plan Share options ("LTSP") over ordinary shares of 2 pence each in the Company ("Ordinary Shares").

Director

Scheme

Year of grant

Exercise price

Options exercised

Ben Stocks

LTSP

2016

2.0p

96,700

Chris Tyler

LTSP

2016

2.0p

67,900

On the same day, the Company was notified that Ben Stocks, Group CEO, and Chris Tyler, Group Finance Director, had sold the following Ordinary Shares in order to meet the cost of exercise, the personal taxation liabilities arising on the options and certain other financial commitments.

Director

Transaction

Price

Number

Ben Stocks

Sale

£5.82

76,700

Chris Tyler

Sale

£5.82

52,900

The Company was also notified on 27 June 2019 of the following purchase on 7 June 2019 by Ben Stocks of Ordinary Shares pursuant to the Group's dividend reinvestment plan ("DRIP").

Director

Transaction

Price

Number

Ben Stocks

DRIP purchase

£5.68

3,513

Following these dealings, Ben Stocks' holding in the Company has increased by 23,513 Ordinary Shares to 762,933 Ordinary Shares, representing approximately 1.7 per cent. of the Company's issued share capital. Chris Tyler's holding in the Company has increased by 15,000 Ordinary Shares to 494,311 Ordinary Shares, representing approximately 1.1 per cent. of the Company's issued share capital.

As at today's date, the total number of voting rights in the Company is 45,843,599. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

For further information, please contact:

Porvair plc

01553 765 500

Chris Tyler, Group Finance Director

Notes to Editors

Porvair is a group of specialist filtration and environmental technology businesses. Its businesses design and manufacture a range of bespoke consumable filtration products that are used in a range of niche filtration markets. It operates in three divisions: Aerospace & Industrial; Laboratory; and Metal Melt Quality.

 

The information below (set out in accordance with the requirements of EU Market Abuse Regulation) provides further detail:

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Christopher Tyler

2.

Reason for the notification

a.

Position/status

CFO

b.

Initial notification

/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Porvair plc

b.

LEI

213800ECKHS8LAQO3C45

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type

of instrument

Identification code

Ordinary shares of 2p

 

 

GB0006963689

b.

Nature of the transaction

 

1) Exercise of LTSP share options

 

2) Sale of ordinary shares

 

c.

Price(s) and volume(s)

 

Price(s)

 

Volume(s)

1)

£0.02

67,900

2)

£5.82

52,900

d.

Aggregated information

· Aggregated volume

· Price

 

 

As above

e.

Date of the transaction

27 June 2019

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

 

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Ben Stocks

2.

Reason for the notification

a.

Position/status

CEO

b.

Initial notification

/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Porvair plc

b.

LEI

213800ECKHS8LAQO3C45

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type

of instrument

Identification code

Ordinary shares of 2p

 

 

GB0006963689

b.

Nature of the transaction

 

1) Exercise of LTSP share options

 

2) Sale of ordinary shares

 

3) Purchase of shares through the dividend reinvestment plan

 

c.

Price(s) and volume(s)

 

Price(s)

 

Volume(s)

1)

£0.02

96,700

2)

£5.82

76,700

3)

£5.68

3,513

d.

Aggregated information

· Aggregated volume

· Price

 

 

As above

e.

Date of the transaction

27 June 2019

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHZMGZVGRKGLZM
Date   Source Headline
14th Feb 201812:02 pmRNSPrice Monitoring Extension
13th Feb 20184:40 pmRNSSecond Price Monitoring Extn
13th Feb 20184:35 pmRNSPrice Monitoring Extension
1st Feb 20185:57 pmRNSBlock listing Interim Review
29th Jan 20187:00 amRNSResults for the year ended 30 November 2017
2nd Jan 201810:35 amRNSHolding(s) in Company
12th Dec 20174:52 pmRNSHolding(s) in Company
8th Dec 20177:00 amRNSPre-close Trading Update and Acquisition
6th Nov 20174:40 pmRNSSecond Price Monitoring Extn
6th Nov 20174:35 pmRNSPrice Monitoring Extension
18th Oct 20174:35 pmRNSPrice Monitoring Extension
13th Oct 201710:00 amRNSDirector's Shareholding and Issue of Equity
10th Oct 20178:27 amRNSHolding(s) in Company
3rd Oct 20174:35 pmRNSPrice Monitoring Extension
28th Sep 20177:00 amRNSAppointment of an Independent NED
19th Sep 20177:00 amRNSTrading Update
17th Aug 201711:34 amRNSHolding(s) in Company
28th Jun 201712:32 pmRNSDirector's Shareholding and Issue of Equity
27th Jun 20177:00 amRNSHalf Yearly Results
22nd Jun 201710:00 amRNSAdditional Listing
5th Jun 20177:00 amRNSTrading Update
11th Apr 201711:50 amRNSAGM resolutions
11th Apr 20177:00 amRNSAGM Statement and Trading Update
10th Apr 20174:51 pmRNSHolding(s) in Company
5th Apr 20177:00 amRNSAcquisition
24th Mar 20178:00 amRNSDirector's Shareholding and Issue of Equity
10th Mar 201712:05 pmRNSPosting of Accounts, AGM and Change of Auditor
22nd Feb 201710:33 amRNSHolding(s) in Company
30th Jan 20177:00 amRNSResults for the year ended 30 November 2016
26th Jan 20174:12 pmRNSHolding(s) in Company
6th Dec 20167:00 amRNSTrading Update and Directorate Change
30th Nov 20168:21 amRNSDirector's shareholding and changes in equity
14th Nov 201610:28 amRNSDr Krishnamurthy Rajagopal
10th Nov 20165:09 pmRNSHolding(s) in Company
3rd Oct 20164:06 pmRNSHolding(s) in Company
3rd Oct 20164:04 pmRNSHolding(s) in Company
3rd Oct 201610:29 amRNSHolding(s) in Company
21st Sep 201612:07 pmRNSSecond Price Monitoring Extn
21st Sep 201612:02 pmRNSPrice Monitoring Extension
21st Sep 20169:28 amRNSHolding(s) in Company
21st Sep 20167:00 amRNSTrading update & appointment of an Independent NED
27th Jun 20167:00 amRNSHalf yearly results
16th Jun 20163:49 pmRNSHolding(s) in Company
16th Jun 20163:48 pmRNSHolding(s) in Company
16th Jun 201611:02 amRNSHolding(s) in Company
2nd Jun 20167:00 amRNSTrading Update
17th May 20163:19 pmRNSHolding(s) in Company
17th May 20163:18 pmRNSHolding(s) in Company
12th Apr 20162:51 pmRNSAGM resolutions
18th Mar 201612:45 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.